Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors
Recruiting · NCT05024214 · Registry updated 2026-03-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Liver Neoplasms, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, benign urinary system neoplasm, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, kidney cancer, kidney disorder, liver disorder, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, renal cell carcinoma, respiratory system disorder, respiratory tract neoplasm, urinary system disorder | Recruiting | Phase 1 / Phase 2 | 2026-03-25 | NCT05024214 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| 3D Medicines (Sichuan) Co., Ltd. | 6 |
23 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.